SEATTLE--(BUSINESS WIRE)--Blaze Bioscience, Inc., the Tumor Paint Company®, a biotechnology company focused on guided cancer therapy, announced today that Heather Franklin, Blaze’s President and CEO, will present the Company’s first Tumor Paint product—BLZ-100—at the SPIE Photonics West Conference on February 13 and 14, 2016. Tumor Paint BLZ-100 will be featured during the BiOS Hot Topics plenary session on the latest technical breakthroughs and promising technologies. The conference is being held in San Francisco, California.
